why choose us

First received: March 29, 2023

Clinical Trial: Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects

Study Status: Completed

Recruit Status: RECRUITING

Condition: Inflammatory Bowel Diseases

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of ATH-063 in Healthy

Brief Summary: The goal of this clinical trial is to test the ATH-063 drug (single and multiple doses) in Healthy Subjects.The clinical trial aims to evaluate the below.Safety of the drugTolerability of the drugPharmacokinetics (PK) (how the human body affects the drug)Pharmacodynamics (PD) (how the drug affects the human body)This will be a single center, Phase 1, First-In-Human, Randomized, Double-Blind (neither the subjects nor the experimenters know which subjects are in the test and control groups), Placebo (a look-alike…

Read more